Clinical Trial Update: Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer [Phase 1]

View source ↗

Summary

This phase 1 trial update reports safety, pharmacokinetics, and preliminary efficacy data for VIR-5500 (AMX-500) in men with hormone-refractory prostate cancer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• VIR-5500 (AMX-500)

Snippet

Sponsor: Vir Biotechnology, Inc. | Conditions: Hormone-refractory Prostate Cancer | Phase 1 | Status: RECRUITING